🇺🇸 FDA
Patent

US 11236044

Selective inhibitors of 12(S)-lipoxygenase (12-LOX) and methods for use of the same

granted A61PA61P7/02

Quick answer

US patent 11236044 (Selective inhibitors of 12(S)-lipoxygenase (12-LOX) and methods for use of the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P7/02